We are live on ! Find out more
LOGC

LogicBio Therapeutics, Inc. Common Stock
LOGC

Delisted

LOGC was delisted on the 15th of November, 2022.

Back to rankings

61 hedge funds and large institutions have $128M invested in LogicBio Therapeutics, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 17 increasing their positions, 14 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 9

21% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 14

3% more funds holding

Funds holding: 59 → 61 (+2)

3% less capital invested

Capital invested by funds: $133M → $128M (-$4.41M)

Holders
61
Holders Change
+2
Holders Change %
+3.39%
% of All Funds
1.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
17
Reduced
14
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
GCP
GSA Capital Partners
United Kingdom
+$913K
2
BCM
Bridgeway Capital Management
Texas
+$811K
3
Wells Fargo
Wells Fargo
California
+$685K
4
BlackRock
BlackRock
New York
+$661K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$199K

Top Sellers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
-$710K
2
Millennium Management
Millennium Management
New York
-$451K
3
JP Morgan Chase
JP Morgan Chase
New York
-$366K
4
Citadel Advisors
Citadel Advisors
Florida
-$248K
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$154K
Name Holding Trade Value Shares
Change 		Change in
Stake
VFA
51
Valeo Financial Advisors
Indiana
$4K +$4.11K +500 New
TWA
52
TCI Wealth Advisors
Arizona
$3K +$2.83K +344 New
Osaic Holdings
53
Osaic Holdings
Arizona
$3K +$2.88K +350 New
CFA
54
Carroll Financial Associates
North Carolina
$3K +$3.52K +428 New
SPIA
55
Steward Partners Investment Advisory
New York
$2.18K +$2.47K +300 New
RE
56
RBC Europe
United Kingdom
$2K – – –
IRC
57
Investors Research Corp
Georgia
$1K -$165 -20 -18%
MF
58
Manchester Financial
California
$1K – – –
SBL
59
Sargent Bickham Lagudis
Colorado
$1K – – –
TFA
60
Toth Financial Advisory
Virginia
$1K – – –
AIG
61
American International Group
New York
$70 +$214 +26 +0.3%
Millennium Management
62
Millennium Management
New York
– -$451K -59,132 Closed
Citadel Advisors
63
Citadel Advisors
Florida
– -$248K -32,430 Closed
Jacobs Levy Equity Management
64
Jacobs Levy Equity Management
New Jersey
– -$154K -20,245 Closed
PPA
65
Parametric Portfolio Associates
Washington
– -$111K -14,563 Closed
Manulife (Manufacturers Life Insurance)
66
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$90K -11,781 Closed
SIS
67
Sound Income Strategies
Florida
– -$5K -658 Closed
FCH
68
Freestone Capital Holdings
Washington
– -$4.58K -600 Closed
ASN
69
Advisory Services Network
Georgia
– -$1K -84 Closed
1 2
3

LOGC Hedge Fund Activity: Q1 2021 in Review

61 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in LogicBio Therapeutics, Inc. Common Stock (LOGC) for Q1 2021, worth a combined $128M — down 3.3% from $133M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new LOGC positions and 9 closed out — a net gain of 3 holders — while 17 added to existing stakes and 14 trimmed.

The largest buyer was GSA Capital Partners, opening a new position worth an estimated $913K. The largest seller was EcoR1 Capital, cutting an estimated $710K.

  • 61 institutional investors held LogicBio Therapeutics, Inc. Common Stock (LOGC) as of Q1 2021, up from 59 in Q4 2020.
  • Funds reported $128M of LogicBio Therapeutics, Inc. Common Stock stock for Q1 2021, down 3.3% quarter-over-quarter.
  • 12 funds opened new LogicBio Therapeutics, Inc. Common Stock positions in Q1 2021 and 9 closed out, a net change of +3 holders.
  • The largest LogicBio Therapeutics, Inc. Common Stock buyer in Q1 2021 was GSA Capital Partners, an estimated $913K added.
  • The largest LogicBio Therapeutics, Inc. Common Stock seller in Q1 2021 was EcoR1 Capital, an estimated $710K sold.

Based on aggregated 13F filings for Q1 2021.